ORIC Pharmaceuticals Ownership | Who Owns ORIC Pharmaceuticals?
ORIC Pharmaceuticals Ownership Summary
ORIC Pharmaceuticals is owned by 117.69% institutional investors, 1.59% insiders. Nextech invest is the largest institutional shareholder, holding 7.49% of ORIC shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.10% of its assets in ORIC Pharmaceuticals shares.
ORIC Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | ORIC Pharmaceuticals | 117.69% | 1.59% | -19.28% |
| Sector | Healthcare Stocks | 50.50% | 12.33% | 37.17% |
| Industry | Biotech Stocks | 49.09% | 12.06% | 38.85% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Nextech invest | 5.29M | 7.49% | $42.66M |
| Blackrock | 4.83M | 7.17% | $34.15M |
| Nextech invest | 7.16M | 6.79% | $77.57M |
| Blackrock funding, inc. /de | 6.82M | 6.47% | $73.90M |
| Ecor1 capital | 6.73M | 6.38% | $72.87M |
| Price t rowe associates inc /md/ | 6.62M | 6.27% | $71.67M |
| Viking global investors lp | 5.13M | 4.86% | $55.52M |
| State street | 4.89M | 4.64% | $53.00M |
| Vanguard group | 4.54M | 4.59% | $37.15M |
| Sr one capital management, lp | 4.62M | 4.38% | $49.98M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Column group | 3.54M | 43.53% | $38.35M |
| Invus financial advisors | 1.01M | 7.98% | $7.12M |
| Nextech invest | 5.29M | 6.92% | $42.66M |
| Sr one capital management, lp | 4.62M | 4.81% | $49.98M |
| Nextech invest | 7.16M | 3.68% | $77.57M |
| Ecor1 capital | 6.73M | 3.54% | $72.87M |
| Nea management company | 4.12M | 2.81% | $44.60M |
| Superstring capital management lp | 406.08K | 2.78% | $4.40M |
| Euclidean capital | 989.41K | 2.44% | $10.72M |
| First turn management | 2.02M | 2.34% | $21.85M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 4.83M | 0.00% | 1.65M |
| D. e. shaw | 1.58M | 0.01% | 1.54M |
| Price t rowe associates inc /md/ | 6.62M | 0.01% | 1.23M |
| State street | 4.89M | 0.00% | 1.19M |
| Algert global | 1.22M | 0.16% | 1.08M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Pfizer | 372.90K | 2.09% | -4.41M |
| Point72 asset management | - | - | -2.92M |
| Commodore capital lp | - | - | -2.00M |
| Paradigm biocapital advisors lp | - | - | -1.70M |
| Avidity partners management lp | - | - | -1.27M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Sixth street partners management company | 677.82K | 0.00% | 677.82K | $7.34M |
| Two sigma investments, lp | 603.66K | 0.00% | 603.66K | $6.54M |
| Hrt financial lp | 153.25K | 0.00% | 153.25K | $1.66M |
| Driehaus capital management | 148.78K | 0.01% | 148.78K | $1.79M |
| Jump financial | 131.40K | 0.01% | 131.40K | $1.42M |
Sold Out
| Holder | Change |
|---|---|
| Capital performance advisors llp | -1.00 |
| Nelson, van denburg & campbell wealth management group | -8.00 |
| Root financial partners | -17.00 |
| True wealth design | -26.00 |
| Coldstream capital management | -45.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 187 | 1.08% | 124,132,386 | 4.00% | 117 | 0.92% | 112 | 14.29% | 43 | -31.75% |
| Mar 31, 2026 | 181 | 9.04% | 114,725,898 | -4.12% | 130 | 0.89% | 94 | -7.84% | 64 | 77.78% |
| Dec 31, 2025 | 56 | -63.87% | 20,254,766 | -80.98% | 20 | 0.11% | 33 | -63.74% | 16 | -52.94% |
| Sep 30, 2025 | 52 | -62.04% | 16,331,312 | -82.02% | 20 | 0.15% | 33 | -54.17% | 13 | -74.00% |
| Jun 30, 2025 | 143 | -0.69% | 93,335,020 | 17.83% | 119 | 0.96% | 75 | -8.54% | 52 | 36.84% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 3.21M | 3.10% | 7.38K |
| Vanguard Morn Total Stk Mkt Idx Investor | 2.92M | 2.82% | 180.40K |
| Vanguard Total Stock Mkt Idx Inv | 2.92M | 2.82% | 180.40K |
| Vanguard US Total Market Shares ETF | 1.88M | 2.65% | - |
| ACAP Strategic A | 2.23M | 2.15% | - |
| iShares Russell 2000 ETF | 1.90M | 1.84% | -33.79K |
| Fidelity Growth Compy Commingled Pl O | 1.28M | 1.81% | - |
| T. Rowe Price Health Sciences | 1.53M | 1.48% | - |
| Fidelity Growth Compy Commingled Pl S | 1.32M | 1.28% | - |
| T. Rowe Price Integrated US Sm Gr Eq | 1.26M | 1.22% | 215.40K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 24, 2026 | Heyman Richard A. | - | Sell | $73.32K |
| Jul 24, 2026 | Heyman Richard A. | - | Sell | $84.14K |
| Jul 06, 2026 | Heyman Richard A. | - | Sell | $3.60K |
| Feb 24, 2026 | Piscitelli Dominic | Chief Financial Officer | Sell | $702.69K |
| Jan 16, 2026 | Heyman Richard A. | - | Sell | $38.41K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | 1 |
| 2026 Q1 | - | 3 |
| 2025 Q4 | - | 6 |
| 2025 Q3 | - | 3 |
| 2025 Q2 | 2 | 9 |
ORIC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools